Comment on Current Investigations into the Postfinasteride Syndrome.

Area of Science:

• Dermatology
• Endocrinology
• Psychiatry

Background:

• Male pattern hair loss (MPHL) is a common dermatologic concern with significant emotional impact.
• Oral finasteride is an effective first-line pharmacologic treatment for MPHL, with a generally favorable safety profile.
• The emergence of 'post-finasteride syndrome' with persistent sexual, somatic, and psychological symptoms after drug cessation is a growing concern.

Purpose of the Study:

• To investigate the plausibility and potential underlying mechanisms of the post-finasteride syndrome.
• To critically evaluate the existing evidence regarding persistent side effects of finasteride.
• To explore alternative explanations for the reported symptoms, including psychiatric factors.

Main Methods:

• Comprehensive review of medical literature on finasteride and its side effects.
• Analysis of neuroendocrinological research and rodent models.
• Comparison of reported symptoms with known psychiatric conditions and the nocebo effect.

Main Results:

• Evidence supporting persistent sexual side effects in low-quality studies with significant bias and nocebo effect.
• No consistent endocrinological or organic abnormalities found in affected individuals.
• Striking similarities to Koro syndrome and emergence following media coverage suggest a potential psychiatric basis.

Conclusions:

• The post-finasteride syndrome is not currently recognized by the medical community.
• The condition may represent a psychiatric disorder, potentially exacerbated by the nocebo effect and media influence.
• Further research is needed to understand the complex interplay of factors contributing to these reported symptoms.